Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease.
Yusuke MiyataniDavid ChoiNatalie K ChoiDavid T RubinPublished in: Digestive diseases and sciences (2023)
Based on our case series, combination therapy with UST and UPA may be effective and appears safe in refractory Crohn's disease and for patients with co-existing extraintestinal manifestations.
Keyphrases